Focusing on dividend stocks investing and financial independence. Follow the latest news, analysis, rating changes of popular dividend stocks.
April 17, 2016
Should You Believe The Monster Yields At GlaxoSmithKline plc And BP plc?
A flurry of dividend cuts across the FTSE 100 has caused investors to become increasingly sceptical over the payout forecasts for many of Britain’s leading blue-chips.
Medicines giant GlaxoSmithKline (LSE: GSK) and oil mammoth BP (LSE: BP) are two such stocks that have come under rising scrutiny from income chasers. But are these concerns truly merited?
If you want to find out, continue reading...
Source: The Motley Fool